The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Adrenocortical carcinoma in the United States: Treatment utilization and prognostic factors
Abstract
BACKGROUND: Adrenocortical carcinoma (ACC) is a rare tumor with a relatively poor prognosis. The authors' objectives were to examine treatment utilization and factors associated with long-term survival after resection of ACC in a large, national, patient population. METHODS: Patients diagnosed with ACC from 1985 to 2005 were identified from the National Cancer Data Base (NCDB). Patient, tumor, treatment, and hospital factors associated with survival after resection were examined. RESULTS: For the current study, 3982 patients with ACC were identified. Median age at diagnosis was 55 years. Median tumor size was 13 cm. Of the patients with nodes examined, 26.5% had nodal metastases. Distant metastases were found on presentation in 21.6% of patients. A total of 57.4% of patients underwent surgical resection alone, whereas 16.0% underwent resection with adjuvant chemotherapy or radiation. A total of 19.4% had margin-positive resections. Treatment utilization remained unchanged from 1985 to 2005 (P = .28). Median follow-up was 24 months. Overall 5-year survival for all patients who underwent resection was 38.6% (median survival, 31.9 months). Multivariable analysis demonstrated a higher risk of death with increasing age, poorly differentiated tumors, involved margins, and nodal or distant metastases. Overall survival remained unchanged from 1985 to 2000 (P = .08). CONCLUSIONS: ACC carries a poor prognosis for patients commonly presenting with large, locally invasive tumors, involved margins, and metastatic disease. Survival is not affected by size but is diminished with increasing age, poorly differentiated tumors, involved margins, and the presence of regional and distant disease. Identification of novel therapies may help to increase survival, which has remained unchanged over the last 20 years.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Analysis of the SEER database gives a slightly older mean age of 55 years (11).”
From Adrenocortical carcinoma (2014) · cites this paper as [11]
In the citing paper
“However, in the United States, 45% of adrenalectomies for ACC are performed in community hospitals, 30% in academic centers, and only 15% in National Cancer Institute-designated Cancer Centers, suboptimal treatment of a rare and aggressive disease requiring specialized knowledge of surgical technique (11).”
From Adrenocortical carcinoma (2014) · cites this paper as [11]
In the citing paper
“an analysis of almost 4000 patients from the National Cancer Data Base, which found that 9% of ACC patients treated with surgery had microscopically positive margins (R1), whereas a further 10% had macroscopically positive margins (R2) (11).”
From Adrenocortical carcinoma (2014) · cites this paper as [11]
In the citing paper
“The outcomes after surgical resection alone have remained suboptimal (11, 244, 267, 269–273).”
From Adrenocortical carcinoma (2014) · cites this paper as [11]
In the citing paper
“patients with positive margins had a dismal prognosis compared with those with uninvolved margins; 5-year survival was 10% after R2 resection, 21% after R1, and 49% after R0 (11).”
From Adrenocortical carcinoma (2014) · cites this paper as [11]
In the citing paper
“ACC has a well-documented propensity for lymphatic dissemination (11, 91, 351), with involved nodal disease in approximately 15% to 27% of patients at the time of surgery (11, 91).”
From Adrenocortical carcinoma (2014) · cites this paper as [11]
In the citing paper
“In the United States, it is used in approximately 10% of cases, according to analyses of both the National Cancer Data Base and the SEER program (4, 11, 90).”
From Adrenocortical carcinoma (2014) · cites this paper as [11]
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,239
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
Devesa, S. S., Blot, W. J., & Fraumeni, J. F. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981115)83:10 · Cited by 2,097
Spiess, P. E., Lee, A. K., Leibovici, D., Wang, X., Do, K.-A., & Pisters, L. L. (2006) · Cancer · doi:10.1002/cncr.21979 · Cited by 1,930
The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States
Bilimoria, K. Y., Stewart, A. K., Winchester, D. P., & Ko, C. Y. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9747-3 · Cited by 1,853
Self-citationComparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors
Weiss, L. M. (1984) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198403000-00001 · Cited by 920
Adrenocortical Carcinoma: Clinical Update
Allolio, B., & Fassnacht, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2639 · Cited by 775
Adjuvant Mitotane Treatment for Adrenocortical Carcinoma
Terzolo, M., Angeli, A., Faßnacht, M., Daffara, F., Tauchmanovà, L., Conton, P. A., Rossetto, R., Buci, L., Sperone, P., Grossrubatscher, E. M., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063360 · Cited by 759
Icard, P., Goudet, P., Charpenay, C., Andreassian, B., Carnaille, B., Chapuis, Y., Cougard, P., Henry, J., & Proye, C. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0047-y · Cited by 543
Flagged first, then by citations
Research works printed but not linked: 3
- 1990, International Classification of Disease for Oncology
- 2000, International Classification of Disease for Oncology
- 2004, Facility Oncology Registry Data Standards
Cited by
Sorted by citations
Items 101–200 of 494
Surgery for adrenocortical carcinoma: When and how?
Sinclair, T. J., Gillis, A., Alobuia, W. M., Wild, H. B. H., & Kebebew, E. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101408 · Cited by 42
Self-citationCurrent Status and Future Targeted Therapy in Adrenocortical Cancer
Alyateem, G., & Nilubol, N. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.613248 · Cited by 42
Therapeutic Management of Advanced Adrenocortical Carcinoma: What Do We Know in 2011?
Baudin, É., Leboulleux, S., Ghuzlan, A. A., Chougnet, C., Young, J., Deandreis, D., Dumont, F., Dechamps, F., Caramella, C., Chanson, P., et al. (2011) · Hormones and Cancer · doi:10.1007/s12672-011-0094-2 · Cited by 42
Adrenal MRI: Techniques and clinical applications
Siegelman, E. S. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23601 · Cited by 40
Nilubol, N., Zhang, L., Shen, M., Zhang, Y., He, M., Austin, C. P., & Kebebew, E. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-198 · Cited by 40
Self-citationA new risk stratification algorithm for the management of patients with adrenal incidentalomas
Birsen, O., Akyüz, M., Dural, A. C., Aksoy, E., Aliyev, S., Mitchell, J. C., SIPERSTEIN, A. E., & Berber, E. (2014) · Surgery · doi:10.1016/j.surg.2014.06.042 · Cited by 39
Nelson, D. W., Chang, S., Bandera, B. C., Fischer, T. D., Wollman, R. C., & Goldfarb, M. R. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6510-x · Cited by 39
Wandoloski, M., Bussey, K. J., & Demeure, M. J. (2009) · Surgical Clinics of North America · doi:10.1016/j.suc.2009.06.019 · Cited by 39
Surgical Management of Adrenocortical Carcinoma
Datta, J., & Roses, R. E. (2015) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2015.08.011 · Cited by 38
Adrenocortical tumors and insulin resistance: What is the first step?
Altieri, B., Tirabassi, G., Casa, S. D., Ronchi, C. L., Balercia, G., Orio, F., Pontecorvi, A., Colao, A., & Muscogiuri, G. (2015) · International Journal of Cancer · doi:10.1002/ijc.29950 · Cited by 39
Curative Surgical Resection of Adrenocortical Carcinoma
Kim, Y., Margonis, G. A., Prescott, J. D., Tran, T. B., Postlewait, L. M., Maithel, S. K., Wang, T. S., Glenn, J. A., Hatzaras, I. S., Shenoy, R. S., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000001527 · Cited by 37
Genetics of Adrenocortical Development and Tumors
Lodish, M. B. (2017) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.01.007 · Cited by 37
Weiss, I. D., Huff, L. M., Evbuomwan, M. O., Xu, X., Dang, H. D., Velez, D. S., SINGH, S. P., Zhang, H. H., Gardina, P. J., Lee, J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19945 · Cited by 39
Martino, M. C. D., van Koetsveld, P. M., Feelders, R. A., de Herder, W. W., Dogan, F., Janssen, J. A. M. J. L., Bruinink, D. H. O., Pivonello, C., Waaijers, A. M., Colao, A., et al. (2019) · Endocrine · doi:10.1007/s12020-019-01869-1 · Cited by 39
Surgical management of adrenal tumors
Germain, A., Klein, M., & Brunaud, L. (2011) · Journal of Visceral Surgery · doi:10.1016/j.jviscsurg.2011.06.003 · Cited by 37
Calcatera, N. A., Hsiung‐Wang, C., Suss, N. R., Winchester, D. J., Moo‐Young, T. A., & Prinz, R. A. (2017) · World Journal of Surgery · doi:10.1007/s00268-017-4290-2 · Cited by 36
Self-citationDysregulation of microRNAs in adrenocortical tumors
Singh, P., Soon, P. S. H., Feige, J., Chabre, O., Zhao, J., Cherradi, N., Lalli, E., & Sidhu, S. B. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.041 · Cited by 35
Huynh, K. T., Lee, D. Y., Lau, B. J., Flaherty, D. C., Lee, J., & Goldfarb, M. R. (2016) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2016.05.015 · Cited by 35
Zheng, G., Li, H., Deng, J.-H., Zhang, X., & Wu, X. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s157518 · Cited by 35
Advances in translational research of the rare cancer type adrenocortical carcinoma
Ghosh, C., Hu, J., & Kebebew, E. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00623-0 · Cited by 34
Self-citationLaparoscopic Adrenalectomy for Large Adrenocortical Carcinoma
Machado, N. O., Qadhi, H. A., Wahaibi, K. A., & Rizvi, S. G. A. (2015) · JSLS Journal of the Society of Laparoscopic & Robotic Surgeons · doi:10.4293/jsls.2015.00036 · Cited by 35
Altieri, B., Sbiera, S., Herterich, S., Francia, S. D., Casa, S. D., Calabrese, A., Pontecorvi, A., Quinkler, M. O., Kienitz, T., Mannelli, M., et al. (2020) · Cancers · doi:10.3390/cancers12020359 · Cited by 34
Therapy of adrenocortical cancer: present and future.
Maluf, D. F., de Oliveira, B. H., & Lalli, E. (2011) · Europe PMC (PubMed Central) · Cited by 34
Srougi, V., Bancos, I., Daher, M., Lee, J. E., Graham, P. H., Karam, J. A., Henriquez, A., McKenzie, T. J., Sada, A., Bourdeau, I., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab865 · Cited by 34
Targeting polo‐like kinase 1, a regulator of p53, in the treatment of adrenocortical carcinoma
Bussey, K. J., Bapat, A., Linnehan, C., Wandoloski, M., Dastrup, E., Rogers, E., Gonzales, P. A., & Demeure, M. J. (2016) · Clinical and Translational Medicine · doi:10.1186/s40169-015-0080-3 · Cited by 34
Shen, Z., Qin, L., Xu, T., Xia, L., Wang, X., Zhang, X., Zhang, X., Zhu, Z., Zhong, S., & Wang, C. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s101701 · Cited by 35
Liu‐Chittenden, Y., Jain, M., Kumar, P., Patel, D., Aufforth, R., Neychev, V. K., Sadowski, S. M., Gara, S. K., Joshi, B. H., Cottle‐Delisle, C., et al. (2015) · Cancer Medicine · doi:10.1002/cam4.449 · Cited by 33
Self-citationLee, C. W., Salem, A. I., Schneider, D. F., LEVERSON, G. E., Tran, T. B., Poultsides, G. A., Postlewait, L. M., Maithel, S. K., Wang, T. S., Hatzaras, I. S., et al. (2016) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-016-3262-4 · Cited by 33
Adrenocortical carcinoma: a literature review
Thampi, A., Shah, E., Elshimy, G., & Correa, R. (2020) · Translational Cancer Research · doi:10.21037/tcr.2019.12.28 · Cited by 32
Suh, I. (2010) · Archives of Surgery · doi:10.1001/archsurg.2009.292 · Cited by 32
Dickson, P. V., Kim, L., Yen, T. W. F., Yang, A. D., Grubbs, E. G., Patel, D., & Solórzano, C. C. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6749-2 · Cited by 32
Adjuvant radiotherapy after surgical resection for adrenocortical carcinoma
Viani, G. A., & Viana, B. S. (2018) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_996_15 · Cited by 31
Comparison between functional and non-functional adrenocortical carcinoma
Sada, A., Asaad, M., Bews, K. A., Thompson, G. B., Young, W. F., Bancos, I., Farley, D. R., Dy, B. M., Lyden, M. L., Habermann, E. B., et al. (2019) · Surgery · doi:10.1016/j.surg.2019.04.066 · Cited by 31
Management of adrenal incidentaloma
Ménégaux, F., Chéreau, N., Peix, J.-L., Christou, N., Lifante, J. C., Paladino, N. C., Sebag, F. A., Ghander, C., Trésallet, C., & Mathonnet, M. (2014) · Journal of Visceral Surgery · doi:10.1016/j.jviscsurg.2014.07.002 · Cited by 32
Leboulleux, S., Deandreis, D., Escourrou, C., Ghuzlan, A. A., Bidault, F., Auperin, A., Travagli, J. P., Lumbroso, J., Schlumberger, M. J., & Baudin, É. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0666 · Cited by 31
Maurice, M. J., Bream, M. J., Kim, S. P., & Abouassaly, R. (2016) · British Journal of Urology · doi:10.1111/bju.13618 · Cited by 31
Kutikov, A., Mallin, K., Canter, D. J., Wong, Y., & Uzzo, R. G. (2011) · The Journal of Urology · doi:10.1016/j.juro.2011.04.072 · Cited by 30
10 rare tumors that warrant a genetics referral
Banks, K. C., Moline, J., Marvin, M. L., Newlin, A. C., & Vogel, K. J. (2012) · Familial Cancer · doi:10.1007/s10689-012-9584-9 · Cited by 30
Protein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical Carcinoma
Arenas, M. A. R., Whitsett, T. G., Aronova, A., Henderson, S., Lobello, J. R., Habra, M. A., Grubbs, E. G., Lee, J. E., Sircar, K., Zarnegar, R., et al. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-6297-1 · Cited by 30
Tierney, J. F., Chivukula, S. V., Poirier, J., Pappas, S. G., Schadde, E., Hertl, M., Kebebew, E., & Keutgen, X. M. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00915 · Cited by 30
Self-citationTerzolo, M., & Faßnacht, M. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0260 · Cited by 30
The role of radiation therapy in the management of adrenal carcinoma and adrenal metastases
Milgrom, S. A., & Goodman, K. A. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23096 · Cited by 30
Adrenocortical carcinoma with inferior vena cava tumor thrombus
Laan, D. V., Thiels, C. A., Glasgow, A. E., Wise, K. B., Thompson, G. B., Richards, M. L., Farley, D. R., Truty, M. J., & McKenzie, T. J. (2016) · Surgery · doi:10.1016/j.surg.2016.07.040 · Cited by 30
Smith, P. M., Kiernan, C. M., Tran, T. B., Postlewait, L. M., Maithel, S. K., Prescott, J. D., Pawlik, T. M., Wang, T. S., Glenn, J. A., Hatzaras, I. S., et al. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6546-y · Cited by 30
The human adrenal cortex: growth control and disorders
Lotfi, C. F. P., Kremer, J. L., Passaia, B. D. S., & Cavalcante, I. P. (2018) · Clinics · doi:10.6061/clinics/2018/e473s · Cited by 31
Chukkalore, D., MacDougall, K. N., Master, V. A., Bilen, M. A., & Nazha, B. (2024) · The Oncologist · doi:10.1093/oncolo/oyae029 · Cited by 29
Adrenocortical carcinoma in patients with MEN1: a kindred report and review of the literature
Wang, W., Han, R., Ye, L., Xie, J., Tao, B., Sun, F., Zhuo, R., Chen, X., Deng, X., Ye, C., et al. (2019) · Endocrine Connections · doi:10.1530/ec-18-0526 · Cited by 29
Medical Approaches in Adrenocortical Carcinoma
Paragliola, R. M., Corsello, A., Locantore, P., Papi, G., Pontecorvi, A., & Corsello, S. M. (2020) · Biomedicines · doi:10.3390/biomedicines8120551 · Cited by 29
Tran, T. B., Maithel, S. K., Pawlik, T. M., Wang, T. S., Hatzaras, I. S., Phay, J. E., Fields, R. C., Weber, S. M., Sicklick, J. K., Yopp, A. C., et al. (2016) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2016.08.568 · Cited by 29
Interleukin‐13 receptor alpha2 is a novel therapeutic target for human adrenocortical carcinoma
Jain, M., Zhang, L., He, M., Patterson, E. E., Nilubol, N., Fojo, A. T., Joshi, B. H., Puri, R. K., & Kebebew, E. (2012) · Cancer · doi:10.1002/cncr.27629 · Cited by 28
Self-citationSurgery for recurrent adrenocortical carcinoma: A multicenter retrospective study
Simon, G., Pattou, F. N., Mirallié, É., Lifante, J. C., Nominé-Criqui, C., Arnault, V., de Calan, L., Caillard, C., Carnaille, B. M. L., Brunaud, L., et al. (2016) · Surgery · doi:10.1016/j.surg.2016.08.058 · Cited by 28
Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors
Martino, M. C. D., Feelders, R. A., de Herder, W. W., van Koetsveld, P. M., Dogan, F., Janssen, J. A. M. J. L., Waaijers, A. M., Pivonello, C., Lamberts, S. W. J., Colao, A., et al. (2014) · Endocrine Related Cancer · doi:10.1530/erc-13-0112 · Cited by 27
Hendricks, A., Müller, S., Faßnacht, M., Germer, C., Wiegering, V. A., Wiegering, A., & Reibetanz, J. (2022) · Cancers · doi:10.3390/cancers14020291 · Cited by 27
Endoscopic adrenalectomy in large adrenal tumors
Asari, R., Koperek, O., & Niederle, B. (2012) · Surgery · doi:10.1016/j.surg.2012.02.003 · Cited by 27
Subramanian, C., & Cohen, M. S. (2018) · Surgery · doi:10.1016/j.surg.2018.04.080 · Cited by 25
Mills, J. K., Khalil, M., Pasieka, J. L., Kong, S., Xu, Y., & Harvey, A. M. (2019) · Surgery · doi:10.1016/j.surg.2019.05.049 · Cited by 25
Rottlerin as a novel chemotherapy agent for adrenocortical carcinoma
Zhu, Y., Wang, M., Zhao, X., Zhang, L., Wu, Y., Wang, B., & Wei-lie, H. (2017) · Oncotarget · doi:10.18632/oncotarget.15221 · Cited by 25
The Impact of Nodal Dissection on Staging in Adrenocortical Carcinoma
Panjwani, S. J., Moore, M. D., Gray, K. D., Finnerty, B. M., Beninato, T. M., Brunaud, L., Fahey, T. J., & Zarnegar, R. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-6064-3 · Cited by 25
Comparative Efficacy of Laparoscopic Versus Robotic Adrenalectomy for Adrenal Malignancy
Mishra, K., Maurice, M. J., Bukavina, L., & Abouassaly, R. (2018) · Urology · doi:10.1016/j.urology.2018.08.037 · Cited by 25
Use of Minimally Invasive Surgery in the Diagnosis and Treatment of Cancer in Dogs and Cats
Balsa, I. M., & Culp, W. T. N. (2019) · Veterinary Sciences · doi:10.3390/vetsci6010033 · Cited by 25
Minimally Invasive Surgery for Primary and Metastatic Adrenal Malignancy
Kiernan, C. M., & Lee, J. E. (2019) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2018.11.011 · Cited by 24
Pathological and Genetic Stratification for Management of Adrenocortical Carcinoma
Clay, M. R., Pinto, E. M., Fishbein, L. M., Else, T., & Kiseljak‐Vassiliades, K. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab866 · Cited by 24
Srougi, V., de Bessa, J., Tanno, F. Y., Ferreira, A. M., Hoff, A. O., Neto, J. E. B., de Almeida, C. M., Almeida, M. Q., Mendonca, B. B., Nahas, W. C., et al. (2017) · International braz j urol · doi:10.1590/s1677-5538.ibju.2017.0095 · Cited by 24
Zhang, F., Zhang, F., Liu, Z., Wu, K., Zhu, Y., & Lu, Y. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01050-0 · Cited by 24
Salvage Therapy With Multikinase Inhibitors and Immunotherapy in Advanced Adrenal Cortical Carcinoma
Miller, K. C., Chintakuntlawar, A. V., Hilger, C. R., Bancos, I., Morris, J. C., Ryder, M. M., Smith, C. Y., Jenkins, S. M., & Bible, K. C. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa069 · Cited by 25
Surgical Management of Adrenocortical Carcinoma: Current Highlights
Cavallaro, G., Tarallo, M., Chiappini, A., Crocetti, D., Polistena, A., Petramala, L., Sibio, S., Toma, G. D., Fiori, E., & Letizia, C. (2021) · Biomedicines · doi:10.3390/biomedicines9080909 · Cited by 23
Time Until Partial Response in Metastatic Adrenocortical Carcinoma Long-Term Survivors
For Comete-Cancer Network, Vezzosi, D., Cao, C. D., Hescot, S., Bertherat, J. Y., Haissaguerre, M., Bongard, V., Drui, D., de la Fouchardière, C., Illouz, F., et al. (2017) · Hormones and Cancer · doi:10.1007/s12672-017-0313-6 · Cited by 23
Kroiß, M., Deutschbein, T., Schlötelburg, W., Ronchi, C. L., Hescot, S., Körbl, D., Megerle, F., Beuschlein, F., Neu, B., Quinkler, M. O., et al. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0747-5571 · Cited by 23
DeLozier, O. M., Stiles, Z. E., Deschner, B. W., Drake, J. A., Deneve, J. L., Glazer, E. S., Tsao, M. W., Yakoub, D., & Dickson, P. V. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-020-08824-9 · Cited by 23
Survival and prognostic factors for adrenocortical carcinoma: a single institution experience
Loncar, Z. M., Djukić, V., Zivaljevic, V. R., Pekmezovic, T. D., Diklić, A., Tatic, S. B., Dundjerović, D., Oluić, B., Slijepčević, N., & Paunovic, I. R. (2015) · BMC Urology · doi:10.1186/s12894-015-0038-1 · Cited by 22
MicroRNA-205 suppresses the growth of adrenocortical carcinoma SW-13 cells via targeting Bcl-2
Wu, Y., Wang, W., Wei-lie, H., Wen-qing, X., XIAO, G., NIE, Q., Ouyang, K., & Chen, D. (2015) · Oncology Reports · doi:10.3892/or.2015.4295 · Cited by 22
Surgical Management of Adrenocortical Carcinoma
Ranvier, G. G. F., & Inabnet, W. B. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.008 · Cited by 22
Salvage Treatment of Adrenocortical Carcinoma with Trofosfamide
on behalf of the German Adrenocortical Carcinoma Study Group, Kroiß, M., Deutschbein, T., Schlötelburg, W., Ronchi, C. L., Neu, B., Müller, H., Quinkler, M. O., Hahner, S., Heidemeier, A., et al. (2016) · Hormones and Cancer · doi:10.1007/s12672-016-0260-7 · Cited by 22
Adrenocortical carcinoma surgery—surgical extent and approach
Vanbrugghe, C., Lowery, A., Rosete, C. G., Taïeb, D., & Sebag, F. A. (2016) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-016-1462-8 · Cited by 22
Argyriou, P., Zisis, C., Alevizopoulos, N., Kefaloyannis, E., Gennatas, C., & Petraki, C. D. (2008) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-6-134 · Cited by 21
STMN1 is Overexpressed in Adrenocortical Carcinoma and Promotes a More Aggressive Phenotype In Vitro
Aronova, A., Min, I. M., Crowley, M. J. P., Panjwani, S. J., Finnerty, B. M., Scognamiglio, T., Liu, Y., Whitsett, T. G., Garg, S., Demeure, M. J., et al. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-6296-2 · Cited by 21
Makary, M. S., Krishner, L. S., Wuthrick, E. J., Bloomston, M. P., & Dowell, J. D. (2018) · World Journal of Clinical Oncology · doi:10.5306/wjco.v9.i1.20 · Cited by 21
Clinical and molecular prognostic factors in adrenocortical carcinoma
Libé, R. (2018) · Minerva Endocrinology · doi:10.23736/s0391-1977.18.02900-0 · Cited by 21
Thomas, A. J., Habra, M. A., Bhosale, P., Qayyum, A., Ahmed, K., Vicens, R., & Elsayes, K. M. (2018) · Abdominal Radiology · doi:10.1007/s00261-018-1603-3 · Cited by 21
Mitsui, Y., Yasumoto, H., Nagami, T., Hiraki, M., Arichi, N., Ishikawa, N., Araki, A., Maruyama, R., Tanaka, Y., Dahiya, R., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1889 · Cited by 20
Metastatic Adrenocortical Carcinoma: a Single Institutional Experience
Owen, D. H., Patel, S. H., Wei, L., Phay, J. E., Shirley, L. A., Kirschner, L. S., Schmidt, C. R., Abdel‐Misih, S., Brock, P. L., Shah, M. H., et al. (2019) · Hormones and Cancer · doi:10.1007/s12672-019-00367-0 · Cited by 20
Key MicroRNA’s and Their Targetome in Adrenocortical Cancer
Chehade, M., Bullock, M., Glover, A. R., Hutvágner, G., & Sidhu, S. B. (2020) · Cancers · doi:10.3390/cancers12082198 · Cited by 20
Serum RARRES2 Is a Prognostic Marker in Patients With Adrenocortical Carcinoma
Liu‐Chittenden, Y., Patel, D., Gaskins, K., Giordano, T. J., Assié, G., Bertherat, J. Y., & Kebebew, E. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1781 · Cited by 19
Self-citationTERT promoter hypermethylation is associated with poor prognosis in adrenocortical carcinoma
Svahn, F., Paulsson, J. O., Stenman, A., Fotouhi, O., Mu, N., Murtha, T. D., Korah, R. M., Carling, T., B�ckdahl, M., Wang, N., et al. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3735 · Cited by 19
Expression of programmed death ligand 1 and 2 in adrenocortical cancer tissues: An exploratory study
Tierney, J. F., Vogle, A., Poirier, J., Min, I. M., Finnerty, B. M., Zarnegar, R., Pappas, S. G., Scognamiglio, T., Ghai, R., Gattuso, P., et al. (2018) · Surgery · doi:10.1016/j.surg.2018.04.086 · Cited by 19
Brain Metastasis in Patients With Adrenocortical Carcinoma: A Clinical Series
Burotto, M., Tageja, N., Rosenberg, A. Z., Mahalingam, S., Quezado, M., Velarde, M., Edgerly, M., & Fojo, T. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2650 · Cited by 19
Sun-Zhang, A., Juhlin, C. C., Carling, T., Scholl, U. I., Schott, M., Larsson, C., & Bajalica‐Lagercrantz, S. (2024) · ESMO Open · doi:10.1016/j.esmoop.2024.103617 · Cited by 18
Chagpar, R., SIPERSTEIN, A. E., & Berber, E. (2014) · Surgical Clinics of North America · doi:10.1016/j.suc.2014.02.009 · Cited by 18
Ectopic adrenocortical carcinoma located in the ovary
Chentli, F., Terki, N., & Azzoug, S. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0224 · Cited by 18
Poorman, C. E., Ethun, C. G., Postlewait, L. M., Tran, T. B., Prescott, J. D., Pawlik, T. M., Wang, T. S., Glenn, J. A., Hatzaras, I. S., Shenoy, R. S., et al. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-6236-1 · Cited by 18
Adrenocortical Cancer Treatment
Long, S. E., & Miller, B. S. (2019) · Surgical Clinics of North America · doi:10.1016/j.suc.2019.04.012 · Cited by 18
Deschner, B. W., Stiles, Z. E., DeLozier, O. M., Drake, J. A., Tsao, M. W., Glazer, E. S., Deneve, J. L., Yakoub, D., & Dickson, P. V. (2020) · Journal of Surgical Oncology · doi:10.1002/jso.26138 · Cited by 18
Epidemiology of Adrenocortical Carcinoma
Faßnacht, M., & Allolio, B. (2009) · Springer eBooks · doi:10.1007/978-0-387-77236-3_3 · Cited by 18
Wang, T. S., Cheung, K., Roman, S. A., & Sosa, J. A. (2012) · Surgery · doi:10.1016/j.surg.2012.08.011 · Cited by 18
Buishand, F. O., Liu‐Chittenden, Y., Fan, Y., Tirosh, A., Gara, S. K., Patel, D., Meerzaman, D. M., & Kebebew, E. (2019) · Surgery · doi:10.1016/j.surg.2019.04.067 · Cited by 18
Self-citationCancer of the Endocrine System
Schneider, D. F., Mazeh, H., Lubner, S. J., Jaume, J. C., & Chen, H. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00071-0 · Cited by 18
Integrative computational immunogenomic profiling of cortisol‐secreting adrenocortical carcinoma
Baechle, J. J., Hanna, D. N., Sekhar, K. R., Rathmell, J. C., Rathmell, W. K., & Baregamian, N. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16936 · Cited by 17
Hughes, M. S., Lo, W. M., Beresnev, T. H., Merino, M. J., Shutack, Y., Ripley, R. T., Hernandez, J. M., & Davis, J. L. (2018) · Journal of Surgical Research · doi:10.1016/j.jss.2018.06.012 · Cited by 17
Characteristics of adrenocortical carcinoma in South Korea: a registry-based nationwide survey
Lim, J. S., Lee, S., Kim, J. H., Kim, J. H., & _, _. (2020) · Endocrine Connections · doi:10.1530/ec-20-0196 · Cited by 17
Balderrama-Brondani, V., Lacombe, A. M. F., Mariani, B. M. P., Montenegro, L. R., Soares, I. C., Neto, J. E. B., Tanno, F. Y., Srougi, V., Chambo, J. L., Mendonca, B. B., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031238 · Cited by 17
Metadata
- Authors
- Bilimoria, K. Y., Shen, W. T., Elaraj, D., Bentrem, D. J., Winchester, D. J., Kebebew, E., & Sturgeon, C.
- Affiliations
- Northwestern University (US)
- University of California, San Francisco (US)
- Corresponding author
- Bilimoria, Karl Y.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2008-10-30
- Volume
- 113
- Issue
- 11
- Pages
- 3130-3136
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1994325777
- Cited by
- 493
- References
- 22
- Citations by year
- 2026: 17 · 2025: 24 · 2024: 29 · 2023: 28 · 2022: 28 · 2021: 45 · 2020: 39 · 2019: 29 · 2018: 39 · 2017: 31 · 2016: 26 · 2015: 35 · 2014: 24 · 2013: 19 · 2012: 29
- FWCI
- 17.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- adrenocortical carcinoma, adrenalectomy, surgical resection, long-term survival, prognostic factors, tumor differentiation, positive resection margins, lymph node metastasis, distant metastasis, adjuvant chemotherapy, adjuvant radiotherapy, treatment utilization, age at diagnosis
- MeSH terms
- Adrenal Cortex Neoplasms, Adult, Aged, Female, Humans, Male, Middle Aged, Prognosis, Registries, United States, Survival Analysis, Treatment Outcome, Adrenocortical Carcinoma, Disease-Free Survival
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
